1-1 of 1
for the CML French Group (FIϕLMC)
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

Clinical Trials & Observations
Martine Gardembas, Philippe Rousselot, Michel Tulliez, Magda Vigier, Agnès Buzyn, Françoise Rigal-Huguet, Laurence Legros, Mauricette Michallet, Christian Berthou, Nathalie Cheron, Frederic Maloisel, François-Xavier Mahon, Thierry Facon, Patrice Berthaud, Joëlle Guilhot, François Guilhot, for the CML French Group (FIϕLMC)
Journal: Blood
Blood (2003) 102 (13): 4298–4305.
https://doi.org/10.1182/blood-2003-04-1010
Published: 2003